1 study found for:    20809380 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis
Condition: Human Immunodeficiency Virus (HIV)
Interventions: Drug: Rilpivirine;   Drug: Placebo

Indicates status has not been verified in more than two years